These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18535620)

  • 21. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein.
    Bian H; Fournier P; Moormann R; Peeters B; Schirrmacher V
    Int J Oncol; 2005 Feb; 26(2):431-9. PubMed ID: 15645128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
    Kalyanasundram J; Hamid A; Yusoff K; Chia SL
    Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective in vitro cytotoxic effect of human cancer cells by bluetongue virus-10.
    Hu J; Dong CY; Li JK; Chen DE; Liang K; Liu J
    Acta Oncol; 2008; 47(1):124-34. PubMed ID: 17851866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of more potent oncolytic paramyxovirus by bioselection.
    Beier R; Hermiston T; Mumberg D
    Gene Ther; 2013 Jan; 20(1):102-11. PubMed ID: 22357510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
    Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmentation of tumor cell immunogenicity by viruses--an approach to specific immunotherapy of cancer.
    Shoham J; Hirsch R; Zakay-Rones Z; Osband ME; Brennert HJ
    Nat Immun Cell Growth Regul; 1990; 9(3):165-72. PubMed ID: 2370876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic vaccinia virus: from bedside to benchtop and back.
    Thorne SH
    Curr Opin Mol Ther; 2008 Aug; 10(4):387-92. PubMed ID: 18683104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.
    Mansour M; Palese P; Zamarin D
    J Virol; 2011 Jun; 85(12):6015-23. PubMed ID: 21471241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
    Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
    PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.
    Buijs P; van Nieuwkoop S; Vaes V; Fouchier R; van Eijck C; van den Hoogen B
    Viruses; 2015 Jun; 7(6):2980-98. PubMed ID: 26110582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus.
    Schirrmacher V; Haas C; Bonifer R; Ahlert T; Gerhards R; Ertel C
    Gene Ther; 1999 Jan; 6(1):63-73. PubMed ID: 10341877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus.
    Zhou C; Tan L; Sun Y; Qiu X; Liao Y; Song C; Liu W; Nair V; Ding C
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31174402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.
    Schirrmacher V
    Expert Opin Biol Ther; 2015; 15(12):1757-71. PubMed ID: 26436571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma.
    Sánchez D; Pelayo R; Medina LA; Vadillo E; Sánchez R; Núñez L; Cesarman-Maus G; Sarmiento-Silva RE
    Viruses; 2015 Dec; 8(1):. PubMed ID: 26703717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion.
    García-Romero N; Palacín-Aliana I; Esteban-Rubio S; Madurga R; Rius-Rocabert S; Carrión-Navarro J; Presa J; Cuadrado-Castano S; Sánchez-Gómez P; García-Sastre A; Nistal-Villan E; Ayuso-Sacido A
    Cells; 2020 Jun; 9(6):. PubMed ID: 32516884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy.
    Zhao H; Janke M; Fournier P; Schirrmacher V
    Virus Res; 2008 Sep; 136(1-2):75-80. PubMed ID: 18538434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.
    Buijs PR; van Eijck CH; Hofland LJ; Fouchier RA; van den Hoogen BG
    Cancer Gene Ther; 2014 Jan; 21(1):24-30. PubMed ID: 24384773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.